MatsukiyoCocokara & Co, formerly Matsumotokiyoshi Holdings Co Ltd, is engaged in retail business, wholesale business and management support business. Retail business is engaged in operating chain stores of drugstores and insurance pharmacies, opening and operating insurance dispensing pharmacies, dispatching pharmacists and others. Wholesale business purchases and sells products handled by group companies and business partners that engage in retail business, develops franchise businesses, and supplies products to franchisees. The Management Support segment is involved in the management of group companies and contracting of indirect business, planning and development of private brand products, asset management and operation, the construction and maintenance of stores, as well as the operation of non-life and life insurance agency business.

Employees

13,371

Sector

Drug Retailers

Calendar

26/09/2024 - Détachement de for dividende intermédiaire

More about the company

Quotes

Date	Price	Change	Volume
19/09/24	2,263.00 ¥	+1.43%	1,213,600
18/09/24	2,231.00 ¥	-0.29%	1,370,900
17/09/24	2,237.50 ¥	0.00%	1,329,600
13/09/24	2,237.50 ¥	-0.97%	1,444,900
12/09/24	2,259.50 ¥	+2.33%	1,441,300

Delayed Quote Japan Exchange, September 19, 2024 at 07:00 am

More quotes

Income Statement and Estimates

More financial data

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2,231.00JPY

Average target price

2,811.43JPY

Spread / Average Target

+26.02%

Consensus

Profit revisions

Estimate revisions

Quarterly earnings, Rate of surprise

Company calendar

Market Closed - Japan Exchange Other stock markets 07:00:00 19/09/2024 BST			5-day change	1st Jan Change
2,263.00 ^JPY	+1.43%		+0.15%	-9.37%

08-14	Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on August 13, 2024.	CI
08-14	MatsukiyoCocokara & Co.'s Equity Buyback announced on August 13, 2024, has closed with 13,224,500 shares, representing 3.17% for ¥29,999.78 million.	CI

Capitalization	900B 6.3B 474B	P/E ratio 2025 *	17.3x	P/E ratio 2026 *	16x
Enterprise value	921B 6.44B 484B	EV / Sales 2025 *	0.72x	EV / Sales 2026 *	0.66x
Free-Float	81.5%	Yield 2025 *	1.89%	Yield 2026 *	1.97%

Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on August 13, 2024.	08-14	CI
MatsukiyoCocokara & Co.'s Equity Buyback announced on August 13, 2024, has closed with 13,224,500 shares, representing 3.17% for ¥29,999.78 million.	08-13	CI
MatsukiyoCocokara & Co. announces an Equity Buyback for 13,224,500 shares, for ¥29,999.78 million.	08-13	CI
MatsukiyoCocokara & Co. authorizes a Buyback Plan.	08-12	CI
Revieve and MatsukiyoCocokara Introduce Beauty Solutions, Transforming the Beauty Experience in Japan	06-27	CI
Certain Shares of AZ-COM MARUWA Holdings Inc. are subject to a Lock-Up Agreement Ending on 3-JUN-2024.	06-02	CI
Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on May 10, 2024.	05-13	CI
MatsukiyoCocokara & Co.'s Equity Buyback announced on May 10, 2024, has closed with 415,000 shares, representing 0.1% for ¥953.26 million.	05-12	CI
MatsukiyoCocokara & Co. announces an Equity Buyback for 420,000 shares, representing 0.1% for ¥964.74 million.	05-10	CI
MatsukiyoCocokara & Co. authorizes a Buyback Plan.	05-09	CI
Aeon Co. Plans to Merge Japan Drugstore Unit Welcia With Rival Tsuruha -- 2nd Update	02-28	DJ
Aeon Co. Plans to Merge Japan Drugstore Unit Welcia With Rival Tsuruha -- Update	02-28	DJ
Aeon Co. Weighs Merger of Drugstore Unit Welcia With Rival Tsuruha -- 3rd Update	02-26	DJ

El Nikkei cae un 0,4%, arrastrado por los minoristas y las casas comerciales -- Market Talk	17/08/23
El Nikkei cae un 0,9% por el temor a que se estanquen las negociaciones sobre el techo de deuda de EEUU -- Market Talk	24/05/23
El Nikkei cae un 0,4% en una probable corrección técnica -- Market Talk	23/05/23
Japon: Matsukiyo discute avec Cocokara pour créer un géant du drugstore	14/08/19

MatsukiyoCocokara & Co. Share Price

Equities

3088

JP3869010003

Drug Retailers

Valuation: MatsukiyoCocokara & Co.

Chart: MatsukiyoCocokara & Co.

Latest news: MatsukiyoCocokara & Co.

Analysts' recommendations: MatsukiyoCocokara & Co.

News in other languages: MatsukiyoCocokara & Co.

Quotes and Performance

Course Extremes

Managers and Directors: MatsukiyoCocokara & Co.

ETFs: MatsukiyoCocokara & Co.

Other Drug Retailers

Financials

Company Profile

Quotes

Income Statement and Estimates

Ratings

Analysts' Consensus

Quarterly earnings, Rate of surprise

1 day	+1.43%
1 week	+0.15%
Current month	-3.62%
1 month	+5.01%
3 months	+3.55%
6 months	-6.12%
Current year	-9.37%

Director	Title	Age	Since
Hiroshi Nishida DFI	Director of Finance/CFO	-	-
Kiyoo Matsumoto PSD	President	51	30/09/07
Takashi Matsuda BRD	Director/Board Member	51	31/03/14

Manager	Title	Age	Since
Namio Matsumoto CHM	Chairman	81	30/09/07
Kiyoo Matsumoto PSD	President	51	30/09/07
Takashi Matsumoto BRD	Director/Board Member	49	31/03/09

Name	Weight	AuM	1st Jan change
NOMURA NEXT FUNDS TOPIX-17 RETAIL TRADE ETF - JPY	3.22%	20 M€	+14.40%
DAIWA ETF MSCI JAPAN ESG SELECT LEADERS INDEX ETF - JPY	0.27%	713 M€	+12.28%
MAXIS JPX-NIKKEI 400 ETF - JPY	0.22%	5,214 M€	+11.18%
NOMURA NEXT FUNDS JPX-NIKKEI INDEX 400 ETF - JPY	0.22%	10,354 M€	+12.57%
NOMURA NEXT FUNDS NOMURA ENTERPRISE VALUE ALLOCATION INDEX ETF - JPY	0.21%	74 M€	+9.96%

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
MATSUKIYOCOCOKARA & CO.	+1.43%	+0.15%	-17.70%	+31.57%	6.34B
JD HEALTH INTERNATIONAL INC.	+5.39%	+5.62%	-41.23%	-68.16%	9.5B
WALGREENS BOOTS ALLIANCE, INC.	-0.55%	+3.09%	-59.40%	-81.84%	7.82B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	+4.91%	+5.65%	-36.38%	-74.36%	5.88B
CLICKS GROUP LIMITED	+1.13%	+2.31%	+49.98%	+28.82%	5.21B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	-1.00%	-3.97%	+94.99%	+195.28%	4.69B
NAHDI MEDICAL COMPANY	+0.46%	-0.76%	-11.34%	-	4.53B
YIFENG PHARMACY CHAIN CO., LTD.	+0.56%	-3.62%	-38.13%	-40.12%	3.06B
WELCIA HOLDINGS CO., LTD.	-0.03%	+0.28%	-26.10%	-52.77%	2.85B
REDCARE PHARMACY NV	+2.33%	-2.94%	+20.66%	-24.23%	2.62B
Average	+1.71%	-0.29%	-6.46%	-9.54%	5.25B
Weighted average by Cap.	+2.20%	+0.07%	-12.65%	-16.57%

	2025 *	2026 *
Net sales	1,065B 7.45B 560B	1,106B 7.74B 582B
Net income	53.54B 374M 28.17B	57.62B 403M 30.32B
Net Debt	-130B -912M -68.65B	-165B -1.15B -86.6B